Skip to NavigationSkip to content

Pharmafile - Medical Communications

-Gilead to lay off one fifth of sales force -GSK to make redundancies at plant in Stevenage -Genentech employee awarded $250,000 over racial...
MSD has revealed that its anti-PD-1 therapy Keytruda (pembrolizumab) has received expanded indication from the FDA to include the first-line...
Janssen has lifted the curtain on data from the first Phase 3 trial investigating the efficacy of Symtuza in treating HIV-1 infection when the...
-Gilead to lay off one fifth of sales force -Indivior shares fall by 70% after allegations of fraud -NICE turns down Astellas' Xtandi in prostate...

Features

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research...

Appointments

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO.

The opioid drugmaker said the decision...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches